While the pace of payment reform is moving quickly, Patrick Conway, MD, MSc, deputy administrator for innovation and quality and chief medical officer at CMS, said he thinks about how to maintain that pace.
While the pace of payment reform is moving quickly, Patrick Conway, MD, MSc, deputy administrator for innovation and quality and chief medical officer at CMS, said he thinks about how to maintain that pace.
Transcript
What gap does the new Accountable Health Communities ACO model fill, and how does it advance HHS’ move to value-based care?
The gap that Accountable Health Communities fills is really linking the social determinants of health with the clinical delivery system. So we’re making an investment at the community level to build that connection. There are 3 tracks that are increasing levels of investment and engagement for patients and consumers.
But the way I describe it to people: imagine a patient who may have multiple social needs—housing, food insecurity, other issues—this will help them connect with those social services that provide those social needs. And there is an evidence base that this is likely able to decrease healthcare costs.
So it’s really linking the social services and the public health system with the clinical care delivery system at the community level.
How do you see the pace of payment reform moving? What are your biggest causes for optimism and concern?
I think we see the pace of payment reform moving quickly right now. I think the shift to alternative payment models, where providers are accountable for quality and total cost of care, has moved more in the last 3 years than we’ve ever seen before.
The question is: how do we maintain that pace? How do we learn what’s working and scale those successes? And how do we learn from various models? So those are the types of things I think about.
The things to think about in terms of concerns or things that could slow down progress are if there are negative unintended consequences in given communities and states. Additionally, I think we always need to invest in supporting providers and communities on this transition. So whether it’s technical assistance or data or information, how do we support the care transformation process?
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More